Trades on 1 secondary market
Valar Labs
Valar Labs is an AI oncology company building diagnostics that interpret solid tumors from routine pathology slides to predict cancer treatment response. Its proprietary CHAI (Computational Histology Artificial Intelligence) platform analyzes digitized H&E-stained slides — trained on 500,000+ pathol
Valar Labs is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.